Hyperparathyroidism and complications associated with Vitamin D deficiency in HIV-infected adults in New York City, New York

AIDS Research and Human Retroviruses

Volumn 28, Issue 9, 2012, Pages 825-832

  Kwan, Candice K ^a,b   Eckhardt, Benjamin ^a,b   Baghdadi, Jonathan ^b   Aberg, Judith A ^a,b  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALKALINE PHOSPHATASE; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; PROTEINASE INHIBITOR; TENOFOVIR; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; BONE TURNOVER; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPARATHYROIDISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OSTEOMALACIA; OSTEOPENIA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; URBAN AREA; VITAMIN D DEFICIENCY;

EID: 84865518881     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0325     Document Type: Article

References (49)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96 (7):1911-1930.
2. Aberg JA, Kaplan JE, Libman H, et al.: Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49 (5):651-681.
3. Hoy J: Bone, fracture and frailty. Curr Opin HIV AIDS 2011;6 (4):309-314.
4. McComsey GA, Tebas P, Shane E, et al.: Bone disease in HIV infection: A practical review and recommendations for HIV care providers. Clin Infect Dis 2010;51 (8):937-946.
5. Brown TT, Cole SR, Li X, et al.: Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165 (10): 1179-1184. (Pubitemid 40720744)
6. Brown TT and Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS 2006;20 (17):2165-2174. (Pubitemid 44684707)
7. Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, and da Silva BA: Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr 2009; 51 (5):554-561.
8. Collin F, Duval X, Le Moing V, et al.: Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1- infected adults. AIDS 2009;23 (8):1021-1024.
9. Triant VA, Brown TT, Lee H, and Grinspoon SK: Fracture prevalence among human immunodeficiency virus (HIV)- infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 2008;93 (9):3499-3504.
10. Womack JA, Goulet JL, Gibert C, et al.: Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 2011;6 (2):e17217.
11. Young B, Dao CN, Buchacz K, Baker R, and Brooks JT: Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 2011;52 (8): 1061-1068.
12. Yin MT, Lu D, Cremers S, et al.: Short-term bone loss in HIVinfected premenopausal women. J Acquir Immune Defic Syndr 2010;53 (2):202-208.
13. Wasserman P and Rubin DS: Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIVinfected men under care. AIDS Patient Care STDS 2010; 24 (4):223-227.
14. Rodriguez M, Daniels B, Gunawardene S, and Robbins GK: High frequency of vitamin D deficiency in ambulatory HIVpositive patients. AIDS Res Hum Retroviruses 2009;25 (1): 9-14.
15. Mueller NJ, Fux CA, Ledergerber B, et al.: High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24 (8):1127-1134.
16. Dao CN, Patel P, Overton ET, et al.: Low vitamin D among HIV-infected adults: Prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011;52 (3):396-405.
17. Stein EM, Yin MT, McMahon DJ, et al.: Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African- American women. Osteoporos Int 2011;22 (2):477-487.
18. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357 (3):266-281.
19. Stechschulte SA, Kirsner RS, and Federman DG: Vitamin D: Bone and beyond, rationale and recommendations for supplementation. Am J Med 2009;122 (9):793-802.
20. Holick MF: Vitamin D: Extraskeletal health. Endocrinol Metab Clin North Am 2010;39 (2):381-400.
21. Overton ET and Yin MT: The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 2011;13 (1):83-93.
22. Welz T, Childs K, Ibrahim F, et al.: Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010;24 (12):1923-1928.
23. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al.: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24 (11):1375-1382.
24. Brown TT and McComsey GA: Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010;15 (3):425-429.
25. Wohl D, Doroana M, Orkin C, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, and Boven K: Change in vitamin D levels smaller and risk of development of severe vitamin D deficiency lower among HIV-1-infected, treatment- naive adults receiving TMC278 compared with EFV: 48-week results from the Phase III ECHO Trial. 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011.
26. IOM: Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine, Washington, DC, 2011.
27. ADA: Standards of medical care in diabetes-2011. Diabetes Care 2011;34 (Suppl 1):S11-S61.
28. DHHS: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2011 1-166 http:// www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL .pdf. Accessed May 27, 2011.
29. Viard JP, Souberbielle JC, Kirk O, et al.: Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS 2011;25 (10):1305-1315.
30. Fox J, Peters B, Prakash M, Arribas J, Hill A, and Moecklinghoff C: Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial. AIDS Res Hum Retroviruses 2011;27 (1):29-34.
31. AdeyemiOM,AgnielD, FrenchAL, et al.:VitaminDdeficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011;57 (3):197-204.
32. Herzmann C and Arasteh K: Efavirenz-induced osteomalacia. AIDS 2009;23 (2):274-275.
33. Fabbriciani G and De Socio GV: Efavirenz and bone health. AIDS 2009;23 (9):1181.
34. Stellbrink HJ, Orkin C, Arribas JR, et al.: Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 2010;51 (8): 963-972.
35. Rosenvinge MM, Gedela K, Copas AJ, et al.: Tenofovirlinked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010;54 (5):496-499.
36. Childs KE, Fishman SL, Constable C, et al.: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 2010;26 (8): 855-859.
37. Chiu KC, Chu A, Go VL, and Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79 (5):820-825. (Pubitemid 41103882)
38. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, and Hu FB: Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010;33 (9):2021-2023.
39. Pittas AG, Dawson-Hughes B, Li T, et al.: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29 (3):650-656. (Pubitemid 44115368)
40. Brar I, Shuter J, Thomas A, Daniels E, and Absalon J: A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr 2007;45 (1):66-71. (Pubitemid 46684444)
41. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al.: HIV infection and the risk of diabetes mellitus. AIDS 2009; 23 (10):1227-1234.
42. Samaras K: Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr 2009;50 (5):499-505.
43. Barber Y, Rubio C, Fernandez E, Rubio M, and Fibla J: Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users. J Infect Dis 2001;184 (10):1279-1288. (Pubitemid 33055572)
44. Mehta S, Giovannucci E, Mugusi FM, et al.: Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010;5 (1): e8770.
45. Spector SA: Vitamin D and HIV: Letting the sun shine in. Top Antivir Med 2011;19 (1):6-10.
46. Diop ME, Bastard JP, Meunier N, et al.: Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses 2006;22 (12):1242-1247. (Pubitemid 46095241)
47. Polgreen PM, Putz D, and Stapleton JT: Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis 2003;37 (4):e53-e56.
48. Glesby MJ, Hoover DR, Shi Q, et al.: Glycated haemoglobin in diabetic women with and without HIV infection: Data from the Women's Interagency HIV Study. Antivir Ther 2010;15 (4):571-577.
49. Eckhardt B, Holzman R, Kwan CK, Baghdadi J, and Aberg J: Glycated hemoglobin A1C as screening for diabetes mellitus in HIV-infected individuals. Conference for Retroviruses and Opportunistic Infections. Vol Poster Abstract #849. Boston, MA, 2011.